Unknown

Dataset Information

Attributable Failure of First-line Cancer Treatment and Incremental Costs Associated With Smoking by Patients With Cancer.


ABSTRACT:

Importance

Previous studies have shown that continued smoking among patients with cancer can increase overall and cancer-specific mortality, risk for second primary cancer, and risk for toxic effects of cancer treatment. To our knowledge, there have been no efforts to estimate additional costs for cancer treatment attributed to smoking.

Objective

To model attributable incremental costs of subsequent cancer treatment associated with continued smoking by patients with cancer.

Design, setting, and participants

For this economic evaluation, a model was developed in 2018 using data from a 2014 US Surgeon General's report that considered expected failure rates of first-line cancer treatment in nonsmoking patients, smoking prevalence, odds ratio of first-line cancer treatmen

SUBMITTER: Warren GW 

PROVIDER: S-EPMC6450325 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature